Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Carcinoma Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Testing effectiveness (Phase 2)Study completedNCT00217633
What this trial is testing

Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+2 more
Gynecologic Oncology Group 38
Testing effectiveness (Phase 2)Study completedNCT00041093
What this trial is testing

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Gynecologic Oncology Group 27
Early research (Phase 1)Study completedNCT02379520
What this trial is testing

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more
Baylor College of Medicine 32
Testing effectiveness (Phase 2)Study completedNCT00026260
What this trial is testing

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT04982237
What this trial is testing

AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Akeso 445
Testing effectiveness (Phase 2)Ended earlyNCT03367871
What this trial is testing

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami 17
Testing effectiveness (Phase 2)Ended earlyNCT00002478
What this trial is testing

Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

Who this might be right for
Cervical CancerOvarian Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT06459687
What this trial is testing

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Lee's Pharmaceutical Limited 440
Not applicableStudy completedNCT00383279
What this trial is testing

Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer

Who this might be right for
Cervical CancerOvarian CancerSarcoma
Wake Forest University Health Sciences 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 49
Not applicableNot Yet RecruitingNCT06878196
What this trial is testing

CtDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasm
Obstetrics & Gynecology Hospital of Fudan University 20
Testing effectiveness (Phase 2)UnknownNCT05310331
What this trial is testing

Donafenib for Recurrent Cervical Cancer

Who this might be right for
Targeted TherapyChemotherapyRecurrent Cervical Carcinoma+4 more
Lei Li 20
Not applicableEnded earlyNCT00669422
What this trial is testing

ChemoFx® PRO - A Post-Market Data Collection Study

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+5 more
Precision Therapeutics 2,756
Large-scale testing (Phase 3)Not Yet RecruitingNCT06870565
What this trial is testing

Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma

Who this might be right for
Gastric-type Endocervical AdenocarcinomaCervical Cancer
Women's Hospital School Of Medicine Zhejiang University 238
Testing effectiveness (Phase 2)UnknownNCT06455046
What this trial is testing

Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer

Who this might be right for
Cervical Cancer Recurrent
Fujian Cancer Hospital 37
Large-scale testing (Phase 3)Study completedNCT00006083
What this trial is testing

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

Who this might be right for
Cervical CancerChronic Myeloproliferative DisordersLeukemia+6 more
Jonsson Comprehensive Cancer Center
Not applicableNot Yet RecruitingNCT06713655
What this trial is testing

Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation

Who this might be right for
High-grade Squamous Intraepithelial Lesions (HSIL)Cervical Conization
Women's Hospital School Of Medicine Zhejiang University 800
Large-scale testing (Phase 3)Study completedNCT00064077
What this trial is testing

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+2 more
Gynecologic Oncology Group 513
Large-scale testing (Phase 3)WithdrawnNCT04943627
What this trial is testing

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Who this might be right for
Advanced CancerMetastatic Cervical Cancer
Agenus Inc.
Next Page